Jim Simons Heron Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

$56.7 Billion
Q2 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,993,800 shares of HRTX stock, worth $3.97 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,993,800

Previous 2,406,486 17.15%

Holding current value

$3.97 Million

Previous $6.67 Million 4.68%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$2.32 - $3.86 $957,431 - $1.59 Million	-412,686 Reduced 17.15%	1,993,800 $6.98 Million
Q1 2024 May 13, 2024	BUY	$1.71 - $3.06 $894,648 - $1.6 Million	523,186 Added 27.78%	2,406,486 $6.67 Million
Q4 2023 Feb 13, 2024	BUY	$0.54 - $1.82 $859,680 - $2.9 Million	1,592,000 Added 546.52%	1,883,300 $3.2 Million
Q3 2023 Nov 14, 2023	SELL	$0.97 - $1.8 $744,766 - $1.38 Million	-767,800 Reduced 72.5%	291,300 $300,000
Q2 2023 Aug 11, 2023	SELL	$1.11 - $2.88 $90,726 - $235,399	-81,736 Reduced 7.16%	1,059,100 $1.23 Million
Q1 2023 May 12, 2023	BUY	$1.51 - $3.25 $1.23 Million - $2.65 Million	814,336 Added 249.41%	1,140,836 $1.72 Million
Q4 2022 Feb 13, 2023	BUY	$2.25 - $4.67 $734,625 - $1.52 Million	326,500 New	326,500 $816,000
Q2 2021 Aug 13, 2021	SELL	$13.27 - $18.48 $2.16 Million - $3 Million	-162,600 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$14.49 - $20.72 $2.36 Million - $3.37 Million	162,600 New	162,600 $2.64 Million
Q4 2020 Feb 10, 2021	SELL	$14.61 - $22.14 $1.97 Million - $2.98 Million	-134,800 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$13.67 - $17.77 $1.44 Million - $1.87 Million	-105,000 Reduced 43.79%	134,800 $2 Million
Q2 2020 Aug 13, 2020	SELL	$10.89 - $21.47 $8.84 Million - $17.4 Million	-812,092 Reduced 77.2%	239,800 $3.53 Million
Q1 2020 May 14, 2020	BUY	$10.23 - $24.56 $8.91 Million - $21.4 Million	870,892 Added 481.16%	1,051,892 $12.3 Million
Q4 2019 Feb 13, 2020	BUY	$17.42 - $26.61 $3.15 Million - $4.82 Million	181,000 New	181,000 $4.25 Million
Q3 2019 Nov 13, 2019	SELL	$16.36 - $21.39 $1.59 Million - $2.08 Million	-97,400 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$16.93 - $26.22 $1.65 Million - $2.55 Million	97,400 New	97,400 $1.81 Million

Others Institutions Holding HRTX

# of Institutions

198

Shares Held

129M

Call Options Held

94.7K

Put Options Held

148K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $236M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account